Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lombard puts funds into US Aorfix bid

This article was originally published in Clinica

Executive Summary

UK cardiovascular device make Lombard Medical Technologies last week announced completion of a £7.4.m ($14m) gross (£6.6m net) ordinary share placing and said the new funds would help it get closer to a US approval of its AAA stent graft, Aorfix. "The aim is to have completed patient enrolment by this time next year and to have filed a PMA after one-year patient follow-up by mid-2009," Lombard CEO Brian Howlett told Clinica. This schedule could theoretically allow for a PMA approval before the end of 2009.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048895

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel